Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Single and Multiple Dose Study of KHK4323 in Healthy Volunteers and Atopic Dermatitis
jRCT2080224566Phase 1Terminated
- Sponsor
- Kyowa Kirin
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in atopic dermatitis (AD) comparing KHK4323 with Placebo (2 arms). Started Feb 2019; status: terminated.
02
Drugs
KHK4323
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2080224566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224566.